EpiGentek Investor

Biotechnology investments.


Invests into

Total Funding: N/A
Headquarters: New York, United States
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investment Stage: N/A
Technology: Immunotherapy
Investor Type: N/A
Founded Date: 2005
Industry: PharmTech